CXBS (Corix Bioscience) Effective Interest Rate on Debt %: 2,747.83% (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Corix Bioscience Effective Interest Rate on Debt %?

Corix Bioscience CXBS -99.00% Effective Interest Rate on Debt % is 2,747.83% as of Sep. 2017.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Corix Bioscience's annualized positive value of Interest Expense for the quarter that ended in Sep. 2017 was $0.95 Mil. Corix Bioscience's average total debt for the quarter that ended in Sep. 2017 was $0.03 Mil. Therefore, Corix Bioscience's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2017 was 2,747.83%.


Corix Bioscience  (OTCPK:CXBS) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Corix Bioscience Effective Interest Rate on Debt % Related Terms


Corix Bioscience Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Effective Interest Rate on Debt % Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Effective Interest Rate on Debt %
Get a 7-Day Free Trial 0.00 0.00 15.38 60.00 7.47

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 29.43 0.00 421.05 2,747.83

CXBS vs BKIT, YBAO, HSTI: Effective Interest Rate on Debt % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Corix Bioscience's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corix Bioscience Effective Interest Rate on Debt % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Corix Bioscience's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Corix Bioscience's Effective Interest Rate on Debt % falls into.



Corix Bioscience Effective Interest Rate on Debt % Calculation

Corix Bioscience's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2016 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jan. 2015 )+Total Debt  (A: Dec. 2016 ))/ count )
=-1  *  -0.385/( (0+5.151)/ 1 )
=-1  *  -0.385/5.151
=7.47 %

where

Total Debt  (A: Dec. 2016 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=5.077 + 0.074
=5.151

Corix Bioscience's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2017 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2017 )+Total Debt  (Q: Sep. 2017 ))/ count )
=-1  *  -0.948/( (0.019+0.05)/ 2 )
=-1  *  -0.948/0.0345
=2,747.83 %

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2017) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 2,747.83% mean?
Corix Bioscience (CXBS) has a Effective Interest Rate on Debt % of 2,747.83% as of Sep. 2017. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Corix Bioscience and its competitors.
Is Corix Bioscience's Effective Interest Rate on Debt % too high?
Corix Bioscience's current Effective Interest Rate on Debt % is 2,747.83%.
How does Corix Bioscience's Effective Interest Rate on Debt % compare to BKIT and YBAO?
Corix Bioscience's Effective Interest Rate on Debt % of 2,747.83% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Drug Manufacturers company?
A good Effective Interest Rate on Debt % depends on the Drug Manufacturers industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Corix Bioscience and its competitors. Corix Bioscience's current Effective Interest Rate on Debt % is 2,747.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current Effective Interest Rate on Debt % of 2,747.83%. The current Effective Interest Rate on Debt % is 2,747.83%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current Effective Interest Rate on Debt % is 2,747.83% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.